Insulin Resistance Syndrome: Difference between revisions

Latest revision as of 04:24, 17 November 2007

Redirect to:

@@ Line 1: / Line 1: @@
-{{subpages}}
+#REDIRECT [[Metabolic syndrome]]
-The '''insulin resistance syndrome''' is a "constellation of findings, including [[central obesity]], [[glucose intolerance]], [[dyslipidemia]], and [[hypertension]], that promotes the development of [[type 2 diabetes mellitus]], [[cardiovascular disease]], [[Cancer|cancer]], [[polycystic ovary syndrome|polycystic ovary syndrome]] (PCOS), and nonalcoholic fatty liver disease".<ref name="pmid16460269">{{cite journal |author=Biddinger SB, Kahn CR |title=From mice to men: insights into the insulin resistance syndromes |journal=Annu. Rev. Physiol. |volume=68 |issue= |pages=123–58 |year=2006 |pmid=16460269 |doi=10.1146/annurev.physiol.68.040104.124723}}</ref>
-As [[Obesity|obesity]] has reached epidemic proportions in many countries of the developed world, a pattern of these findings has become recognized. Also called the metabolic syndrome, the dysmetabolic syndrome, or syndrome X, this association of [[Physiology|physiologic findings]] is the focus of current research in [[medicine]].
-== References ==
-<references />